1
|
Ducos C, Rigo M, Larroumet A, Delyfer MN, Korobelnik JF, Monlun M, Foussard N, Poupon P, Haissaguerre M, Blanco L, Mohammedi K, Rigalleau V. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory. Diabetes Metab 2020; 47:101156. [PMID: 32387701 DOI: 10.1016/j.diabet.2020.03.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2019] [Revised: 03/18/2020] [Accepted: 03/31/2020] [Indexed: 01/25/2023]
Abstract
AIMS As diabetic retinopathy (DR) can occur even in well-controlled patients with type 2 diabetes (T2D), our study sought to determine whether it might be related to 'glucose memory' by evaluating patients' HbA1c over previous years and their skin autofluorescence (SAF). METHODS In 334 patients with T2D and HbA1c levels≤8%, their available values of HbA1c from previous years were collected, and their SAF measured by an advanced glycation end-product (AGE) reader. Binary logistic regression analysis was then used to correlate DR with previously recorded HbA1c levels and to SAF, with adjustment for DR risk factors [age, gender, BMI, duration of diabetes, arterial hypertension, diabetic kidney disease (DKD), blood lipid levels and statin treatment]. RESULTS Our patients were mostly men (58.4%) aged 63±10years, with a duration of diabetes of 13±10years and HbA1c=7.1±0.7%. Of these patients, 84 (25.1%) had DR, which was associated with longer duration of diabetes and greater prevalence of DKD. A total of 605 HbA1c values from previous years were collected for time periods -4±3 months (n=255), -16±4months (n=152), -30±4months (n=93) and -62±26 months (n=105). After adjustment, the association between DR and having an HbA1c higher than the median was significant only for the oldest previous HbA1c values: OR=6.75, 95% CI: 1.90-23.90. Moreover, SAF values were higher in those with DR [2.95±0.67 arbitrary units (AU)] vs 2.65±0.65 AU with no DR (P<0.01) and were also associated with the oldest previous HbA1c values (P<0.01). CONCLUSION Our study found that 25.1% of our well-controlled T2D patients had DR, which was related to both their HbA1c levels from 5years prior to study admission and their SAF values, a marker of glucose memory.
Collapse
Affiliation(s)
- C Ducos
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France.
| | - M Rigo
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - A Larroumet
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M-N Delyfer
- Department of Ophthalmology, CHU de Bordeaux, 33000 Bordeaux, France
| | - J-F Korobelnik
- Department of Ophthalmology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M Monlun
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - N Foussard
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - P Poupon
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - M Haissaguerre
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - L Blanco
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - K Mohammedi
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| | - V Rigalleau
- Department of Endocrinology-Nutrition-Diabetology, CHU de Bordeaux, 33000 Bordeaux, France
| |
Collapse
|
2
|
Barbet-Massin MA, Rigalleau V, Blanco P, Mohammedi K, Poupon P, Belin E, Poursac N, Cadart O, Blanco L. Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report. Diabetes Metab 2020; 47:101143. [PMID: 31981714 DOI: 10.1016/j.diabet.2020.01.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Revised: 12/31/2019] [Accepted: 01/01/2020] [Indexed: 11/29/2022]
Affiliation(s)
- M-A Barbet-Massin
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France.
| | - V Rigalleau
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | - P Blanco
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | - K Mohammedi
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | - P Poupon
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | | | - N Poursac
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | - O Cadart
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| | - L Blanco
- Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France
| |
Collapse
|
3
|
Foussard N, Baillet-Blanco L, Poupon P, Monlun M, Mohammedi K, Cougnard-Grégoire A, Delcourt C, Helmer C, Rigalleau V. Markers of glycation and neonatal hypoglycaemia in gestational diabetes mellitus. Diabet Med 2020; 37:160-162. [PMID: 31693204 DOI: 10.1111/dme.14167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- N Foussard
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - L Baillet-Blanco
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - P Poupon
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - M Monlun
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - K Mohammedi
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
| | - A Cougnard-Grégoire
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - C Delcourt
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - C Helmer
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| | - V Rigalleau
- Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
- University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France
| |
Collapse
|
4
|
Ducos C, Rigalleau V, Foussard N, Cambos S, Poupon P, Monlun M, Blanco L, Haissaguerre M, Grouthier V, Velayoudom-Cephise FL, Mohammedi K. Why might pumps fail in pregnant women with Type 1 diabetes? Diabet Med 2020; 37:159-160. [PMID: 31264729 DOI: 10.1111/dme.14063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/01/2019] [Indexed: 11/26/2022]
Affiliation(s)
- C Ducos
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - V Rigalleau
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - N Foussard
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - S Cambos
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - P Poupon
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - M Monlun
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - L Blanco
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - M Haissaguerre
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - V Grouthier
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - F-L Velayoudom-Cephise
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| | - K Mohammedi
- Endocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, France
| |
Collapse
|
5
|
Poupon P, Foussard N, Helmer C, Cougnard-Gregoire A, Rajaobelina K, Delcourt C, Lamireau T, Haissaguerre M, Blanco L, Alexandre L, Mohammedi K, Rigalleau V. Serum fructosamine predicts macrosomia in well-controlled hyperglycaemic pregnant women: An observational cross-sectional study. Diabetes Metab 2019; 46:219-222. [PMID: 31325500 DOI: 10.1016/j.diabet.2019.07.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2019] [Revised: 06/29/2019] [Accepted: 07/07/2019] [Indexed: 11/18/2022]
Abstract
AIM While serum fructosamine may be a good marker of glucose control in pregnant women with diabetes, its relationship with macrosomia is still uncertain. METHODS In 130 hyperglycaemic women with singleton pregnancies (117 gestational diabetes mellitus, 13 pregestational diabetes), serum fructosamine and HbA1c levels were measured at 25±7 weeks of gestation. Levels in mothers of infants with and without macrosomic newborns (birth weight>4000g and/or large-for-gestational-age birth weight>90th percentile) were compared using logistic regression analysis adjusted for macrosomia risk factors. RESULTS These 130 pregnant women were 33±5 years old; their BMI before pregnancy was 27.7±6.9kg/m2, and they gained 7.5±5.1kg during the first 6 months of gestation. Glucose control was good according to HbA1c levels (5.3±0.3%; 34±2mmol/mol), yet 17/130 (13%) newborns had macrosomia: 3900±227g vs 3057±512g (P<0.001) in the others. These mothers were older and had higher parity, whereas their BMI scores before pregnancy and gestational weight gains did not differ. Fructosamine levels were also higher at 221±40μmol/L vs 192±22μmol/l (P<0.001), respectively, and remained significant even after adjusting for maternal age, BMI, parity, type of diabetes, antecedents of macrosomia and excessive gestational weight gain. By contrast, HbA1c did not differ between the two groups. In fact, nearly two-thirds (64.7%) of the mothers of macrosomic newborns had fructosamine levels>200μmol/l vs 31.9% of mothers with non-macrosomic newborns (P<0.05). CONCLUSION High fructosamine levels are associated with macrosomia in the newborns of well-controlled hyperglycaemic pregnant women.
Collapse
Affiliation(s)
- P Poupon
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France
| | - N Foussard
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France
| | - C Helmer
- Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - A Cougnard-Gregoire
- Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - K Rajaobelina
- Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - C Delcourt
- Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - T Lamireau
- Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - M Haissaguerre
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France
| | - L Blanco
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France
| | - L Alexandre
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France
| | - K Mohammedi
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France; Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France
| | - V Rigalleau
- Nutrition-Diabetology, hôpital Haut-Lévêque, CHU de Bordeaux, 1, avenue de Magellan, F-33600 Pessac, France; Inserm U1219, Bordeaux Population Health Research Centre, F-33000 Bordeaux, France.
| |
Collapse
|
6
|
Moulin G, Bouchet B, Poupon P. [Reticulate erythema with mucinosis (R. E. M. Steigleder syndrome) (author's transl)]. Ann Dermatol Venereol 1977; 104:309-11. [PMID: 407829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
We described a case similar to the four cases reported by Steigleder, Gartman and Linker in 1974 and entitled: "R.E.M. syndrome reticular erythematous mucinosis, a new entity?". In our case, clinical and histological findings were strictly identical to those previously reported. Furthermore, we detected no antibodies in the cutaneous lesions.
Collapse
|